Polypeptide Production via Cysteine Sulfinic Acid Decarboxylase Overexpression

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing recombinant proteins in animal cells are limited by low yield and efficiency, and there is a lack of understanding on how increased β-alanine concentration affects protein production.

Innovation Solution

Using cells that strongly express cysteine sulfinic acid decarboxylase and a taurine transporter to increase β-alanine production, which enhances the yield of desired polypeptides by neutralizing fatigue substances and maintaining cell survival.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If animal cells are used for recombinant protein production, then post-translational modification and folding capabilities are improved, but production yield and efficiency deteriorate

Engineering Contradiction:
Improvepost-translational modification capabilityVSAvoidproduction yield
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The invention changes the intracellular chemical environment by increasing β-alanine concentration through overexpression of cysteine sulfinic acid decarboxylase. This parameter change (β-alanine concentration) improves both cell survival and protein production yield, resolving the contradiction between maintaining modification capability and improving productivity.

Inventive Principle:
Principle #35Parameter changes

2Ease of manufacture

If conventional cell culture methods are used, then production process simplicity is maintained, but cell survival ratio and production efficiency deteriorate due to fatigue substance accumulation

Engineering Contradiction:
Improveprocess simplicityVSAvoidcell survival ratio
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The invention enables cells to self-neutralize fatigue substances (lactate and ammonia) through endogenous β-alanine production. The overexpressed cysteine sulfinic acid decarboxylase catalyzes cysteine conversion to β-alanine, which then neutralizes acidic and basic fatigue substances, improving cell survival without adding external agents or complicating the process.

Inventive Principle:
Principle #25Self-service

3Reliability

If β-alanine is added to culture medium, then antioxidant action and pH buffering are improved, but intracellular β-alanine concentration increase is insufficient

Engineering Contradiction:
Improveantioxidant actionVSAvoidintracellular β-alanine concentration
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The invention performs preliminary action by pre-installing the biosynthetic capability within cells through cysteine sulfinic acid decarboxylase overexpression. This enables cells to autonomously produce β-alanine in advance, ensuring sufficient intracellular concentration for neutralizing fatigue substances, rather than relying on external addition that fails to achieve adequate intracellular levels.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly increases the yield of recombinant proteins by improving β-alanine concentration within cells, leading to higher antibody production and maintaining cell survival ratios, even in the absence of added β-alanine.

Implementation Method 1

cysteine sulfinic acid decarboxylase (CSAD) (EC 4.1.1.29)...synthesizing β-alanine from aspartic acid

Methodology Applied
Scientific EffectDecarboxylation:

Implementation Method 2

β-alanine, by itself, has pH-buffering action and antioxidant action

Methodology Applied
Scientific EffectpH buffering:

Implementation Method 3

β-alanine, by itself, has pH-buffering action and antioxidant action

Methodology Applied
Scientific EffectAntioxidant action: Oxidation

Data Source

PatentUS9181540B2Method for production of polypeptide
Publication Date: 2015.11.10 CHUGAI PHARMA CO LTD
  • US9181540B2 patent drawing
  • US9181540B2 patent drawing
  • US9181540B2 patent drawing

AI summary

The present invention provides a method capable of producing a natural or recombinant protein in high yield. The present invention relates to a method of producing a polypeptide, comprising culturing a cell which strongly expresses cysteine sulfinic acid decarboxylase and has a transferred DNA encoding a desired polypeptide and thereby allowing the cell to produce the polypeptide. Hamster cysteine sulfinic acid decarboxylase, a DNA encoding the same, a recombinant vector and a transformed cell are also provided.